Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 54. Отображено 54.
15-12-2016 дата публикации

광학 활성을 갖는 인돌린 유도체 또는 이의 염의 신규 제조 방법

Номер: KR0101686087B1

... 본 발명은 의약품의 제조 원료로서 유용한 하기 일반식 Ⅰ로 표시되는 광학 활성을 갖는 인돌린 유도체 또는 이의 염의 제조방법에 관한 것이다: 일반식 I 본 발명의 방법은 테레프탈레일 클로라이드(terephthaloyl chloride)를 출발물질로 도입하여 인돌린 유도체 또는 이의 염의 제조시 연결고리로 이용함으로써, 효율성을 높였으며, 중간물질의 확인, 정제 및 공정의 편의성이 크게 개선되었고, 안정성이 우수하여 반응의 효율을 증가시켰으며, 고가의 백금 촉매 대신에 저가의 다루기 용이한 아연을 이용하여 수율을 개선시켰고, 마지막 공정에서 광학순도를 확보하기 위해서 아민기에 벤질기를 도입(일반식 Ⅲ, 바람직하게는 화학식 23)함으로써 재결정만으로도 광학순도가 우수한 상기 일반식 Ⅰ로 표시되는 인돌린 유도체 또는 이의 염을 제조할 수 있다.

Подробнее
06-01-2016 дата публикации

Crystal of Glyceryl Phosphoryl Choline and Method for Preparing Thereof

Номер: KR0101582302B1

... 본 발명은 신규한 글리세릴 포스포릴 콜린(glyceryl phosphoryl choline) 결정 및 이의 제조 방법에 관한 것이다. 본 발명의 글리세릴 포스포릴 콜린 결정은 그 제조에 있어 용매 환경에서 결정 석출 온도 및 교반 시간을 조절함으로써, 신규한 결정을 수득할 수 있으며, 시딩(seeding)과정이 불필요하여 종래 방법에 비해 제조과정이 용이하다. 본 발명의 결정은 용해온도가 100℃ 이상 이면서, 열안정성 및 결정다형의 분석 결과를 통해 열역학적 경시 변화가 일어나지 않는 안정한 고상(solid form)임이 확인되어 제제학적으로 매우 유용하다. 또한, 흡습성 시험 결과 우수한 흡습성의 프로파일을 보유하고, BD(bulk density) 및 TD(tap density)는 제형 제조에 적합한 값을 나타내며 입자 분포도가 매우 균일하고 정규분포의 대칭적 특성을 가져 제제의 용이성을 갖는다. 이러한 본 발명의 글리세릴 포스포릴 콜린 결정(Ⅲ 및 Ⅳ형)은 뇌기능 개선제로서 치매 치료제로 이용될 수 있다.

Подробнее
09-12-2022 дата публикации

폐섬유화증의 예방 또는 치료용 약학 제제

Номер: KR20220163289A
Принадлежит:

... 본 개시는 폐섬유화증의 치료 또는 예방을 위한 화학식 1 화합물의 의학적 용도에 관한 것이다. 본 개시는 또한, 화학식 1 화합물과 Nintedanib의 병용요법에 관한 것이다.

Подробнее
14-03-2023 дата публикации

암 세포 성장을 억제하는 피리미딘 유도체 및 이의 의약 용도

Номер: KR102510072B1
Принадлежит: 주식회사 온코빅스

... 본 발명은 암 세포의 성장을 억제하는 신규 피리미딘 유도체 화합물 및 이의 약학적으로 허용 가능한 염을 제공한다. 본 발명은 이러한 화합물 또는 이의 약학적으로 허용 가능한 염을 포함하는 약학 조성물을 제공한다. 본 발명은 또한 이러한 피리미딘 유도체 화합물 및 이의 약학적으로 허용 가능한 염을 유효성분으로 이용하는 것을 특징으로 하는, 폐암의 치료를 위한 의약 용도를 제공한다. 본 발명은 또한 본 발명에 따른 화합물, 이의 염 또는 이들을 포함하는 조성물의 유효한 양을 치료가 필요한 개체에게 투여하는 것을 포함하는 폐암의 치료 방법을 제공한다.

Подробнее
29-03-2018 дата публикации

ACID ADDITION SALT OF BENZIMIDAZOLE DERIVATIVE

Номер: WO2018056697A1
Принадлежит:

The present invention relates to pidolate and malate salts of a compound represented by chemical formula 1 and preparation methods therefor, wherein the compound has preventive and therapeutic uses for a disease mediated by acid pump antagonistic activity and is excellent in liquid-phase stability, solid-phase stability, solubility in water, precipitation stability, and hygroscopicity.

Подробнее
16-12-2022 дата публикации

3성분 프로드럭, 이의 약학적 조성물 및 의약 용도

Номер: KR20220165891A
Принадлежит:

... 본 개시는 투여 후 모노메틸 푸마레이트 (monomethyl fumarate)를 생성할 수 있는 신규 화합물, 이들을 유효성분으로 포함하는 약학 조성물, 이들의 의약 용도에 관한 것이다.

Подробнее
15-10-2015 дата публикации

Asymmetric ortho-Terphenyl Derivatives and Organic light emitting device Comprising the Same

Номер: KR0101558966B1
Принадлежит: 단국대학교 산학협력단

... 본 발명은 비대칭 오르쏘-터페닐(ortho-terphenyl) 유도체 유기발광 화합물 및 이를 포함하는 유기발광 소자에 관한 것이다. 본 발명에서 개시하는 화합물은 세 개의 벤젠고리가 서로 ortho 위치에 치환되어 높은 입체 장애로 인해 치환기 간 컨쥬게이션 확장을 최소화함으로써 우수한 삼중항 에너지를 유지할 뿐 아니라, 양쪽 말단 벤젠고리에 각각 정공 수송 치환기와 전자 수송 치환기가 결합되어 정공 주입·수송 및 전자 주입·수송 특성이 우수하다. 본 발명에서 개시하는 화합물은 뛰어난 양자효율, 전류효율 및 전력효율과 함께 우수한 청색 및 녹색 인광 발광 특성을 가져, 효율적인 인광 호스트 재료로 유용하게 이용될 수 있다.

Подробнее
19-02-2018 дата публикации

ACID ADDITION SALT OF BENZIMIDAZOLE DERIVATIVE

Номер: KR101829706B1
Принадлежит: CJ HEALTHCARE CORPORATION

The present invention relates to a malate salt and a pidolate salt, represented by chemical formula 1, ensuring excellent moisture absorptiveness, precipitation stability, solubility in water, and stability in liquid and solid phases, and used for preventing and treating diseases mediated by acid pump antagonistic activities. The present invention further relates to a production method thereof. COPYRIGHT KIPO 2018 ...

Подробнее
27-02-2018 дата публикации

콜린 알포세레이트와 커큐민의 공결정 제조방법

Номер: KR0101832562B1

... 본 발명은 콜린 알포세레이트-커큐민 공결정(Choline alfoscerate - curcumin cocrystal) 및 이의 제조 방법을 제공한다. 본 발명의 콜린 알포세레이트-커큐민 공결정은 그 제조에 있어 콜린 알포세레이트의 결정형, 혼합 속도, 용매 환경에 따라 공결정 형성 속도, 공결정의 조성 비율이 다른 공결정 화합물을 형성 할 수 있다.

Подробнее
02-09-2015 дата публикации

SOLID ANTIVIRAL AGENT AND PREPARING METHOD THEREOF

Номер: KR101548724B1
Принадлежит: HUONS CO., LTD., JI, JUN HONG, J2H BIOTECH

The present invention relates to a novel crystal form of a tenofovir disoproxil free base. According to the present invention, the tenofovir disoproxil free base ensures to enhance a stability of a medicine by reducing an impurity production during storage by being able to minimize a production of impure elements due to changes by a time flow compared to a tenofovir disoproxil fumarate or a previously known tenofovir disoproxil free base. In addition, the novel crystal form of the tenofovir disoproxil free base has an improved hygroscopicity, an excellent solubility in each pH, and physicochemically outstanding properties, thereby being able to be used as a useful active ingredient for a pharmaceutical composition. COPYRIGHT KIPO 2015 ...

Подробнее
23-06-2017 дата публикации

CRYSTALLINE POLYMORPH OF L-CARNITINE OROTATE, PRODUCTION METHOD THEREOF, OR USE THEREOF

Номер: KR1020170071431A
Принадлежит:

Provided is a type 1 crystalline polymorph of L-carnitine orotate, a production method thereof, or a use thereof. The type 1 crystalline polymorph of L-carnitine orotate can be used as a pharmaceutical composition for preventing or treating liver disease. COPYRIGHT KIPO 2017 ...

Подробнее
30-06-2016 дата публикации

CRYSTALLINE FEBUXOSTAT PIDOLATE SALT AND METHOD FOR PREPARING SAME

Номер: WO2016104960A3
Автор: RYU, Hyung Chul
Принадлежит:

The present invention relates to a novel febuxostat pidolate salt used as a gout therapeutic agent and a method for preparing same. In preparing the febuxostat pidolate salt of the present invention, an equivalent and stirring time of the pidolate is adjusted in a special solvent environment, thereby enabling the obtaining of a novel crystalline salt of optimal ratio with excellent purity and yield. The novel febuxostat pidolate salt of the present invention has a chemical purity and manufacturing yield that is more excellent than a conventional febuxostat free base, exhibits excellent acid base, thermal stability, and photostability, has a solubility that is more excellent than a conventional febuxostat free base, and the particle size thereof is finer and more homogeneous than a conventional febuxostat free base, and thus is very pharmaceutically useful.

Подробнее
31-03-2016 дата публикации

A Novel Method for Preparing of Telmisartan

Номер: KR0101607661B1
Принадлежит: 주식회사 파마코스텍

... 본 발명은 ARB(안지오텐신 Ⅱ 수용체 차단제)계 고혈압제로 이용되는 텔미사르탄(telmisartan)의 제조 방법 및 상기 방법에 의해 제조된 텔미사르탄(telmisartan)에 관한 것이다. 본 발명의 방법은 텔미사르탄 제조 과정 중 중간체를 수득하기 위한 축합반응을 이온성 액체를 포함하는 용매에서 실시하여, 종래 방법에 비해서 반응시간을 1-2 시간으로 크게 단축 시키고, 수산화기를 포함하는 물의 비율을 조절함으로써, 텔미사르탄 제조를 위한 중간체의 가수분해 반응을 실시하여, 여과성, 공정 속도 및 공정 편의성을 크게 개선시키며 추가 정제 없이 고순도 및 고수율의 텔미사르탄을 수득할 수 있다.

Подробнее
23-07-2015 дата публикации

GLYCERYL PHOSPHORYL CHOLINE CRYSTAL AND PREPARATION METHOD THEREFOR

Номер: WO2015108355A1
Принадлежит:

The present invention relates to a novel glyceryl phosphoryl choline crystal and a preparation method therefor. With respect to the preparation of the glyceryl phosphoryl choline crystal of the present invention, a novel crystal can be obtained by controlling the crystal precipitation temperature and the stirring time in the solvent environments, and a preparation process is simple compared with a conventional method by not requiring a seeding step. It was ascertained that the crystal of the present invention is a stable solid form in which the melting temperature is 100°C or higher and there is no thermodynamic aging through the analysis result of thermal stability and crystal polymorphism, and thus the crystal is very pharmaceutically useful. In addition, the crystal possesses an excellent hygroscopicity profile from hygroscopicity test results, the bulk density (BD) and the tap density (TD) exhibit values suitable for preparing a dosage form, and the particle distribution degree is very ...

Подробнее
27-05-2015 дата публикации

METHOD FOR PREPARING CLOPIDOGREL BISULPHATE CRYSTAL FORM I

Номер: KR1020150056723A
Принадлежит:

The present invention relates to a clopidogrel bisulphate (CLP) crystal form I preparation method. According to the present invention, the method uses an ionic liquid as an anti-solvent to control the polymorphic transition or the phase transition of the crystal form I more efficiently than a CLP crystal form I preparation method using a conventional organic solvent. Accordingly, the present invention can ensure the stability of the CLP crystal form I in the solution and increase the yields. The present invention can also provide a pharmaceutical composition including the CLP crystal form I prepared by using the method as an active ingredient to alleviate, prevent, and treat the platelet-related diseases. COPYRIGHT KIPO 2015 (AA) Maintain Form I for two hours ...

Подробнее
21-09-2016 дата публикации

NOVEL SYNTHESIS METHOD OF OPTICALLY ACTIVE INDOLINE DERIVATIVES OR SALTS THEREOF

Номер: KR1020160109041A
Принадлежит:

The present invention relates to a synthesis method of optically active indoline derivatives or salts thereof, which are represented by general formula I and useful as a starting material for the production of drugs. By introducing terephthaloyl chloride as a starting material and using the same as a link in the synthesis of indoline derivatives or salts thereof, the present invention increases efficiency, greatly facilitates confirmation of intermediates, purification, and processes, and also increases the efficiency of reaction due to excellent stability. By using inexpensive and easy-to-handle zinc instead of expensive platinum catalyst, the present invention improves the yield thereof. By introducing a benzyl group into an amine group (general formula III, preferably chemical formula 23) to ensure optical purity in the final process, the present invention can produce, merely by means of recrystallization, optically pure indoline derivatives or salts thereof, represented by the general ...

Подробнее
06-08-2020 дата публикации

MONOMETHYL FUMARATE PRECURSOR DRUG COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF

Номер: WO2020159228A1
Принадлежит:

The present invention provides: novel compounds capable of producing monomethyl fumarate after the compounds are administered; pharmaceutical compositions comprising same as active ingredients; and pharmaceutical uses thereof for treating or alleviating various diseases including immune system abnormalities, neurodegeneration, and/or inflammatory diseases.

Подробнее
19-02-2016 дата публикации

POWER SAVING SYSTEM

Номер: KR101591377B1
Принадлежит: ER TECH CO., LTD.

The present invention provides a power saving system comprises: a load; a wire; a first branched wire; a power saving device; a second branched wire; and a higher harmonic wave absorption circuit. The load is provided with power from a power supply to be operated. The wire is connected to the load. The first branched wire is branched from the wire. The power saving device is connected to the first branched wire to be operated. The second branched wire is branched from the first branched wire between a wire branched from the first branched wire and the power saving device. The higher harmonic wave absorption circuit is included in the second branched wire. According to the present invention, the power saving device is installed on the wire such that a method for constructing the power saving system is simplified and efficiency in saving power can be uniformly secured. COPYRIGHT KIPO 2016 ...

Подробнее
06-02-2017 дата публикации

METHOD AND ELECTRONIC APPARATUS FOR STABILIZING VIDEO

Номер: KR1020170013102A
Принадлежит:

As to a method for stabilizing a video in an electronic apparatus, disclosed is a method for stabilizing a video, which includes the steps of: determining shaking correction regions corresponding to each of a plurality of frames in the whole region of each of the plurality of frames, based on information about preset magnification and shaking information about the plurality of frames, obtained through an image sensor; generating output frames corresponding to each of the plurality of frames by increasing the shaking correction regions with the preset magnification; and providing the video including the output frames. COPYRIGHT KIPO 2017 (AA) Start (BB) End (S410) Obtaining a plurality of frames through an image sensor (S420) Receiving a user input requesting to increase with a preset magnification about the plurality of frames (S430) Obtaining shaking information about the plurality of frames (S440) Determining shaking correction regions corresponding to each frame in the whole region of ...

Подробнее
28-02-2023 дата публикации

지방간염, 지방증 또는 섬유증의 예방 또는 치료용 복합 제제

Номер: KR20230027388A
Автор: 김재선, 유형철, 임지웅
Принадлежит:

... 본 개시는 2가지 유효 성분을 포함하는, 지방간염, 지방증 및/또는 섬유증의 치료 또는 예방용 약학 제제에 관한 것이다. 즉, 본 개시는 복합 제제에 관한 것이다. 본 개시는 또한 병용 요법에 관한 것이다. 본 개시는 2가지 유효 성분을 병용하여 지방간염, 지방증 및/또는 섬유증의 치료 또는 예방 효과를 시너지적으로 높일 수 있다는 점에 기초한다.

Подробнее
22-05-2017 дата публикации

NOVEL FENOFIBRIC ACID PRODRUG HAVING IMPROVED BIOAVAILABILITY

Номер: KR1020170055610A
Принадлежит:

The present invention relates to a novel fenofibric acid prodrug having improved bioavailability. According to the present invention, the fenofibric acid prodrug of the present invention shows higher bioavailability than existing fenofibric acid. Therefore, the fenofibric acid prodrug of the present invention can be developed as an effective therapeutic agent for treating hyperlipemia or the like. COPYRIGHT KIPO 2017 ...

Подробнее
18-04-2023 дата публикации

마그네슘-세리네이트의 신규한 결정형 및 이의 제조방법

Номер: KR102522508B1
Принадлежит: 주식회사 아스트로젠

... 본 발명은 화학식 1로 표시되는 마그네슘-세리네이트의 신규한 결정형 및 이의 제조 방법에 관한 것으로, 본 발명의 결정형은 열 및 수분 안정성이 우수하고, 장기간 보관 시에도 분해 및 결정형의 전이가 발생하지 않고 안정하게 보존될 수 있어 약제의 의약원료로 유용하게 사용될 수 있다. [화학식 1] ...

Подробнее
10-12-2018 дата публикации

금속 양이온이 제거된 초고순도 플루오로설포닐이미드의 제조방법

Номер: KR0101926856B1

... 본 발명은 금속양이온을 완전히 제거한 플루오로설포닐이미드염의 제조 방법에 관한 것이다. 본 발명의 방법은 경제적으로 매우 효율적인 방법으로서, 플루오로설포닐이미드 함량에 대하여 또는 리튬염 및 수화물 함량에 대하여 1% 이하의 크라운에테르 사용만으로 금속양이온을 완전히 제거한 플루오로설포닐이미드염을 제조할 수 있다. 이로 인해, 수득된 플루오로설포닐이미드염의 효율을 확보하고, 전지 효율 또한 개선될것으로 기대된다. 한편, 본 발명의 방법에 의해 제조된 불순물의 함유량이 저감된 플루오로설포닐이미드염은 특히, 전해질로서 사용하였을 경우 이차전지, 캐퍼시터, 콘덴서, 태양 전지 등의 전기화학 디바이스의 용량의 저하가 발생하기 어려운 고성능 전해질 플루오로설포닐이미드염을 제공할 수 있다.

Подробнее
13-06-2019 дата публикации

NOVEL PYRIMIDINE DERIVATIVE HAVING EFFECT OF INHIBITING CANCER CELL GROWTH AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Номер: WO2019112344A1
Принадлежит:

The present invention provides a novel pyrimidine derivative compound and a salt thereof. The pyrimidine derivative compound effectively inhibits the growth of cancer cells in which c797s-mutated EGFR expression and MET amplification, which are major resistance mechanisms of third generation EGFR anticancer drugs, have occurred, thereby being effectively usable in the treatment of lung cancer.

Подробнее
30-06-2017 дата публикации

APPARATUS AND METHOD FOR GENERATING TIME LAPSE IMAGE

Номер: KR1020170074538A
Принадлежит:

According to an embodiment of the present disclosure, an apparatus for generating a time lapse image comprises the following: a photographing unit photo-electrically converting incident light to generate a video signal; a processor determining a sampling interval of a time-lapse photographing process according to time based on a reference value obtained in real time while the time-lapse photographing is performed, sampling a plurality of input frames generated from the video signal during the time-lapse photographing at the sampling interval, stabilizing a plurality of sampled selected frames among the plurality of input frames using a window determined based on the sampling interval, and compressing the plurality of selected frames at an output frame rate to generate a time-lapse image file; and a storage unit for storing the time-lapse image file. COPYRIGHT KIPO 2017 (AA) Sampling interval (BB) Change the reference value (C1,C2) Photographing time ...

Подробнее
25-04-2023 дата публикации

ALK 및/또는 EGFR 돌연변이 키나제 억제 효과를 나타내는 화합물 및 이의 의약 용도

Номер: KR20230054567A
Принадлежит:

... 본 개시는 ALK 과발현, ALK 돌연변이, EGFR 과발현, EGFR 돌연변이 등에 대해 억제 활성을 나타내는 신규 화합물 및 이의 의약 용도를 제공한다. 본 개시는 이러한 화합물 또는 이의 약학적으로 허용 가능한 염을 포함하는 약학 조성물을 제공한다. 본 개시에 따른 화합물들은 ALK 돌연변이 및 EGFR 돌연변이 모두에 대해 뛰어난 억제 활성을 나타낼 뿐만 아니라, 의약품의 활성 성분으로 이용되기에 바람직한 물리화학적 및 약물동력학적 특성을 가진다.

Подробнее
07-03-2025 дата публикации

모노메틸 푸마레이트 유도체 및 이들의 약학적 조성물

Номер: KR102777432B1
Принадлежит: (주)애거슨바이오

... 본 발명은 투여 후 모노메틸 푸마레이트 (monomethyl fumarate)를 생성할 수 있는 신규 화합물, 이들을 유효성분으로 포함하는 약학 조성물, 이들의 면역체계 이상, 신경퇴행 및/또는 염증성 질환의 치료 또는 개선 의약 용도를 제공한다.

Подробнее
30-01-2020 дата публикации

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NONALCOHOLIC STEATOHEPATITIS

Номер: WO2020022708A1
Принадлежит:

The present invention relates to a medical use of a compound, of chemical formula 1, for treating, alleviating or preventing nonalcoholic steatohepatitis (NASH) and/or hepatic fibrosis.

Подробнее
25-07-2016 дата публикации

CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME

Номер: KR1020160087959A
Принадлежит:

The present invention relates to a carbazole derivative organic light emitting compound and an organic light emitting device comprising the same. In the compound disclosed in the present invention, a substituent introduced at the ortho position induces the steric distortion in the organic light emitting compound to disconnect the pie conjugation, thereby minimizing the expansion of the conjugation between substituents due to a high steric hindrance, thus maintaining excellent triplet energy, and a hole transport substituent and an electron transport substituent are respectively bound to a benzene ring, thereby exhibiting excellent hole injection transport and electron injection transport characteristics. The compound disclosed in the present invention has excellent blue and green phosphorescent characteristics together with superior quantum efficiency, current efficiency, and power efficiency, and thus can be favorably used as an efficient phosphorescent host material. COPYRIGHT KIPO 2016 ...

Подробнее
12-12-2017 дата публикации

METHOD FOR SEPARATING SUCROSE BY SELECTIVE CRYSTALLIZATION

Номер: KR1020170136663A
Принадлежит:

The present invention relates to a method for separating sucrose by selective crystallization, in which it was confirmed that it is possible to selectively crystallize and separate the sucrose, a pure disaccharide, through drowning-out crystallization by dissolving Angelica gigas in an organic solvent and using an ionic liquid as an anti-solvent. COPYRIGHT KIPO 2018 ...

Подробнее
21-06-2018 дата публикации

THREE-COMPONENT COCRYSTAL

Номер: WO2018111044A1
Принадлежит:

The present invention relates to a method for preparing a three-component cocrystal comprising kojic acid, tranexamic acid, and nicotinamide. The method of the present invention is characterized in that a two-component cocrystal is first prepared, and then a three-component cocrystal is prepared, wherein when, regardless of the blending ratio of tranexamic acid, nicotinamide, and kojic acid used in the reaction, the molar ratio of three components, tranexamic acid : nicotinamide : kojic acid is 1 : 1 : 1 in the resultant three-component cocrystal, a most stable solid form was shown. The three-component cocrystal prepared by the method of the present invention can maintain physical and chemical stability when used in a solid-phase or liquid-phase cosmetic composition, and thus can be applied to various cosmetic compositions.

Подробнее
29-10-2015 дата публикации

SOLID FORM ANTIVIRAL AGENT AND PREPARATION METHOD THEREFOR

Номер: WO2015163724A1
Принадлежит:

The present invention relates to a novel crystal form of Tenofovir disoproxil free base. The amount of related substances generated according to an elapsed time can be minimized in the Tenofovir disoproxil free base, according to the present invention, compared with Tenofovir disoproxil fumarate or a conventional Tenofovir disoproxil free base, and thus the stability of a preparation can be increased by lowering the amount of generated impurities in a product storage process. In addition, the novel crystal form of Tenofovir disoproxil free base of the present invention has improved hygroscopicity, excellent solubility according to pH, and excellent physical and chemical properties, and thus can be used as a useful active ingredient of a pharmaceutical composition.

Подробнее
12-11-2015 дата публикации

Method for Preparing of Crystalline Form I of Clopidogrel Bisulphate

Номер: KR0101567438B1
Принадлежит: 대구가톨릭대학교산학협력단

... 본 발명은 클로피도그렐 황산염(clopidogrel bisulphate; CLP) 결정형 Ⅰ형의 제조방법에 관한 것이다. 본 발명의 방법은 이온성 액체를 반용매(anti-solvent)로 사용함으로써, 일반 유기용매를 이용한 클로피도그렐 황산염(CLP) 결정형 Ⅰ형의 제조 방법 보다 결정형 Ⅰ형의 다형 전이(상전이) 현상을 제어 하였다. 이로 인해, 용액 내에서 클로피도그렐 황산염(CLP) 결정형 Ⅰ형의 안정성을 확보하고, 생성 수율 또한 개선시켰다. 한편, 본 발명의 방법에 의해 제조된 클로피도그렐 황산염(CLP) 결정형 Ⅰ형을 유효성분으로 하여 혈소판 관련 혈관 질환의 개선, 치료 또는 예방용 약제학적 조성물을 제공할 수 있다.

Подробнее
29-12-2017 дата публикации

CRYSTALLINE POLYMORPHS OF VARENICLINE FREE BASE, PREPARATION METHOD THEREOF OR USE THEREOF

Номер: KR1020170143141A
Принадлежит:

The present invention relates to a crystalline polymorphic form 3 of varenicline free base, a preparation method thereof and uses thereof. The crystalline polymorphic form 3 of varenicline free base has excellent thermodynamic stability and has physicochemical properties suitable for preparing formulations. The crystalline polymorphic form 3 of varenicline free base can be used for treating nicotine dependence, indulgence, abstinence disorder or symptoms so a composition of the present invention can be prescribed for prohibiting smoking. COPYRIGHT KIPO 2018 ...

Подробнее
13-03-2018 дата публикации

SOLID COMPLEX COMPRISING CURCUMIN AND L-CARNITINE AND ORAL COMPOSITION COMPRISING SAME

Номер: KR1020180026612A
Принадлежит:

The present invention relates to a complex of curcuminoid (or curcumin) or a turmeric (Curcuma Longa) extract and L-carnitine which can secure the homogeneous water dispersibility of curcumin and the hygroscopicity improvement effect of L-carnitine at the same time. The homogeneous solid complex of the present invention has homogeneous water dispersibility even when no additional excipient is added, and allows an easy development of formulations such as beverage preparations and the like compared to conventional curcumin or turmeric extract powder. In addition, the homogeneous solid complex of the present invention has an excellent bioabsorption ratio compared to conventional curcumin powder. COPYRIGHT KIPO 2018 (AA) Individual 1 (BB) Individual 2 (CC) Individual 3 ...

Подробнее
04-10-2018 дата публикации

METHOD OF MANUFACTURING ULTRAPURE FLUOROSULFONYLIMIDE WITHOUT METAL CATION

Номер: KR1020180107808A
Принадлежит:

The present invention relates to a method of manufacturing fluorosulfonylimide salt without any metal cation. As an economically efficient method, the method of the present invention is capable of manufacturing fluorosulfonylimide salt without any metal cation by using only no more than 1% of crown ether in proportion to the content of fluorosulfonylimide or the content of lithium salt and hydrates. Thus, the efficiency of the obtained fluorosulfonylimide salt is secured, and cell efficiency is also improved. In the meantime, especially when the fluorosulfonylimide salt with a reduced impurity content is used as an electrolyte, the capacity of an electrochemical device such as a secondary cell, a capacitor, a condenser, a solar cell, and the like is hardly degraded. COPYRIGHT KIPO 2018 ...

Подробнее
19-03-2025 дата публикации

Prodrug of Norepinephrine Reuptake Inhibitor and Method for Preparing the Same

Номер: KR20250038193A
Автор: 황수경, 유형철
Принадлежит:

The present invention relates to a novel prodrug of the active metabolite of atomoxetine. The present invention also relates to a pharmaceutically acceptable salt of the atomoxetine prodrug, a pharmaceutical composition containing same, a combination, or a use thereof. The novel prodrug of the active metabolite of atomoxetine has an effect of treating or preventing attention-deficient/hyperactivity disorder (ADHD), cognitive decline, ischemic stroke of a subject.

Подробнее
27-09-2018 дата публикации

METHOD FOR PREPARING ULTRAPURE FLUOROSULFONYL IMIDE WITH METAL CATION REMOVED

Номер: WO2018174574A1
Принадлежит:

The present invention relates to a method for preparing a fluorosulfonyl imide salt with a metal cation completely removed. The method of the present invention is a very efficient method in an economic view, and a fluorosulfonyl imide salt with a metal cation completely removed can be prepared by the use of only a crown ether in 1% or less relative to the content of a fluorosulfonyl imide or the content of a lithium salt or a hydrate. Therefore, it is expected that the efficiency of the obtained fluorosulfonyl imide salt is ensured and the battery efficiency is also improved. Meanwhile, the fluorosulfonyl imide salt with a reduced impurity content, prepared by the method of the present invention, especially when used as an electrolyte, can provide a highly functional electrolytic fluorosulfonyl imide salt, which is unlikely to reduce capacity of an electrochemical device, such as a secondary battery, a capacitor, a condenser, or a solar cell.

Подробнее
09-01-2019 дата публикации

변이 상피세포성장인자 수용체 키나아제 저해제로서 융합 피리미딘 유도체

Номер: KR1020190003242A
Принадлежит:

... 본 발명은 신규 융합 피리미딘 유도체 화합물에 관한 것이다. 본 발명의 화합물은 엑손 19결실, L858R 변이, 엑손 20삽입, T790M 변이 상피세포성장인자 수용체 키나아제를 효과적으로 억제할 수 있다. 따라서, 본 발명에 따른 신규 융합 피리미딘 유도체는 상기 변이 상피세포성장인자 수용체 키나아제의 활성화에 의해 유발되는 암 치료에 이용할 수 있다.

Подробнее
15-09-2022 дата публикации

신규한 오르트산염 중간체를 이용한 카르니틴 오르트산염의 제조방법

Номер: KR20220125856A
Принадлежит:

... 본 발명은 신규한 오르트산염 중간체를 이용한 카르니틴 오르트산염의 제조방법 에 관한 것으로, 보다 상세하게는 유기용매 또는 정제수에 용해성이 낮은 오르트산에 3차 아민류를 첨가하여 신규한 오르트산 3차 아민염으로 제조한 후, 카르니틴 염산염과의 산염기 교환반응을 수행함으로써, 별도의 결정화 용매를 사용하지 않고도 단일 반응용매 내에서 불순물의 제거가 용이하여 고수율 및 고순도의 카르니틴 오르트산염을 제조할 수 있는 방법에 관한 것이다.

Подробнее
22-06-2017 дата публикации

CRYSTALLINE POLYMORPH OF L-CARNITINE OROTATE, PRODUCTION METHOD THEREFOR, OR USE THEREOF

Номер: WO2017105090A1
Принадлежит:

The present invention provides the Form 1 crystalline polymorph of L-carnitine orotate, a production method therefor, and a use thereof. The Form 1 crystalline polymorph of L-carnitine orotate of the present invention can be used as a pharmaceutical composition for the prevention or treatment of liver disease.

Подробнее
25-05-2018 дата публикации

SOLID PREPARATION COMPRISING GLYCERYL PHOSPHORYL CHOLINE WITH IMPROVED HYGROSCOPICITY AND USES OR MANUFACTURING METHOD THEREOF

Номер: KR1020180054955A
Принадлежит:

The present invention relates to a solid preparation comprising glyceryl phosphoryl choline using orotic acid as an adsorbent, and to uses or a manufacturing method thereof. The solid preparation containing the glyceryl phosphoryl choline and orotic acid of the present invention can be prepared as a solid type by overcoming the disadvantages related to the stability and production cost of a conventional soft capsule formulation and improving the hygroscopicity, and can be used as a pharmaceutical composition for preventing or treating cranial nerve diseases including brain dysfunction, cognitive disorder, and the like. COPYRIGHT KIPO 2018 ...

Подробнее
02-07-2015 дата публикации

NOVEL METHOD FOR PREPARING TELMISARTAN

Номер: WO2015099327A1
Принадлежит:

The present invention relates to a method for preparing telmisartan used as an angiotensin-II receptor blocker (ARB)-based hypertension medicine and telmisartan prepared by the method. According to the method of the present invention, a condensation reaction for obtaining an intermediate during a telmisartan preparing procedure is conducted in a solvent containing an ionic liquid, thereby significantly shortening the reaction time by 1-2 hours compared with the conventional method; and a hydrolysis reaction of the intermediate for preparing telmisartan is conducted by controlling the ratio of water containing a hydroxyl group, thereby significantly improving filtering efficiency, the process rate, and process convenience and obtaining high-purity and high-yield telmisartan without further purification.

Подробнее
03-07-2015 дата публикации

NOVEL MANUFACTURING METHOD OF TELMISARTAN

Номер: KR1020150075187A
Принадлежит:

The present invention relates to a manufacturing method of telmisartan used as an angiotensin II receptor blocker (ARB)-based hypertension medicine and telmisartan manufactured by the method wherein a condensation reaction for obtaining an intermediate during a telmisartan manufacturing procedure is conducted in a solvent with an ionic liquid, thereby significantly shortening the reaction time by one to two hours compared with the conventional method; and a hydrolysis reaction of the intermediate for manufacturing telmisartan is conducted by controlling the ratio of water with a hydroxyl group, thereby significantly improving filtering efficiency, the process rate, and process convenience and obtaining high-purity and high-yield telmisartan without further purification. COPYRIGHT KIPO 2015 ...

Подробнее
04-01-2023 дата публикации

신규한 디아민 화합물 및 이를 포함하는 폴리이미드 중합체

Номер: KR20230001494A
Принадлежит:

... 본 발명은 신규한 디아민 화합물 및 이를 포함하는 폴리이미드 중합체에 관한 것으로서, 더욱 상세하게 디아민 화합물은 하기 화학식 1의 화합물이고, 폴리이미드 중합체는 방향족 테트라카르복실산 이무수물과 하기 화학식 1의 디아민 화합물을 중합시켜 제조되고, 하기 화학식 2를 반복단위로 함으로써, 저온에서 단시간에 가열 처리하여 유연성, 내열성 및 투과율이 우수한 필름을 제조할 수 있는 폴리이미드 중합체에 관한 것이다: [화학식 1] ...

Подробнее
27-08-2020 дата публикации

MONOMETHYL FUMARATE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USING SAME

Номер: WO2020171507A1
Принадлежит:

The present invention provides: novel compounds capable of producing monomethyl fumarate after administration; pharmaceutical compositions comprising same as active ingredients; and pharmaceutical uses thereof for treatment or alleviation of immune system disorders, neurodegeneration, and/or inflammatory diseases.

Подробнее
02-07-2020 дата публикации

COMPOUNDS USEFUL FOR TREATMENT OR PREVENTION OF MUSCULAR DYSTROPHY AND DERIVATIVES FOR TREATMENT, AMELIORATION OR PREVENTION OF MUSCULAR DYSTROPHY IN MEDICINAL USE THEREOF

Номер: WO2020138935A1
Принадлежит:

The present invention relates to a novel compound and a medicinal use of the novel compound. In particular, the present invention relates to a novel compound useful for the treatment and/or prevention of muscular dystrophy, including Duchenne muscular atrophy, and a medicinal use of the novel compound.

Подробнее
10-04-2017 дата публикации

METHOD FOR MANUFACTURING COCRYSTAL OF CHOLINE ALFOSCERATE AND CURCUMIN

Номер: KR1020170038990A
Принадлежит:

The present invention is to provide a choline alfoscerate-curcumin cocrystal and a manufacturing method thereof. The choline alfoscerate-curcumin cocrystal can form a cocrystal compound having different forming speeds and composition ratios of cocrystals according to a crystal form of choline alfoscerate, a mixing ratio and a solvent environment. The method comprises the following steps: (a) mixing and stirring solid choline alfoscerate and curcumin; (b) cooling the product in the step (a), and mixing and stirring the product again; and (c) drying the product in the step (b) and obtaining cocrystals. COPYRIGHT KIPO 2017 ...

Подробнее
26-03-2020 дата публикации

EDARAVONE PRODRUG COMPOUND AND PHARMACEUTICAL USE THEREOF IN TREATMENT OR ALLEVIATION OF NEURODEGENERATIVE OR MOTOR NEURON DISEASE

Номер: WO2020060092A1
Принадлежит:

The present invention provides a novel prodrug of an edaravone compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising same as an active ingredient, and a use thereof in treatment or alleviation of neurodegenerative and/or motor neuron disease.

Подробнее
27-07-2015 дата публикации

CRYSTAL OF GLYCERYL PHOSPHORYL CHOLINE AND METHOD FOR PREPARING SAME

Номер: KR1020150086160A
Принадлежит:

The present invention relates to novel crystal of glyceryl phosphoryl choline and a method for preparing the same. According to the method, the novel crystal can be obtained by adjusting crystal precipitation temperature and agitation time in a solvent environment. The method is easier than the prior method because a seeding process is not needed. The crystal is proven to have a melting point of 100°C or higher and to be a stable solid form without change over time based on result of analysis on thermal stability and polymorphism of the crystal, and thus is very useful in terms of formulation. Moreover, the crystal has: a profile of excellent moisture absorption properties as a result of moisture absorption result; proper bulk density (BD) and tap density (TD) proper to produce formulation; uniform particle distribution; and symmetrical characteristics of normalized distribution. Therefore, the crystal can be formulated in an easy manner. The crystal of glyceryl phosphoryl choline of the ...

Подробнее
04-09-2017 дата публикации

CO-CRYSTAL OF ANDROSTENONE AND VANILLIN, METHOD OF PREPARING SAME, OR USE OF SAME

Номер: KR1020170100313A
Принадлежит:

The present invention relates to a co-crystal of androstenone and vanillin, a method of preparing the same, and a use of the same. The co-crystal of androstenone and vanillin of the present invention has a rigid lattice structure so as to be free of sublimation property of the androstenone, thereby having excellent stability when stored for a long period in a raw material state. Additionally, since water-solubility is significantly improved, the co-crystal is completely dissolved when preparing a pump-spray agent, and no precipitation occurs even if the co-crystal is stored for a long period under refrigerated conditions. Further, the content of the co-crystal of the present invention compared to the initial content does not decrease over time, and no related compounds are produced. Additionally, the co-crystal not only has a vanilla scent preferred by animals, but also can very effectively calm animals to be stabilized when sprayed thereon, and the effect would be obvious without using ...

Подробнее
20-04-2018 дата публикации

생체이용률이 향상된 신규한 페노피브르산 전구약물

Номер: KR0101850119B1

... 본 발명은 생체이용률이 향상된 신규한 페노피브르산 전구약물에 관한 것이다. 본 발명에 따르면, 본 발명의 페노피브르산 전구약물은 기존의 페노피브레이트에 비해 높은 생체이용률을 나타내다. 따라서 본 발명의 페노피브르산 전구약물은 고지혈증 등의 치료를 위한 효과적인 치료제로 개발될 수 있다.

Подробнее
20-05-2016 дата публикации

ELECTRONIC ELEMENT USING FLAT COIL AND TRANSFORMER USING SAME

Номер: KR101622333B1
Принадлежит: ATUM

The present invention relates to an electronic element using a flat coil and a transformer using the same generated by using a compression type or a screen printing method, and is designed to provide a coil element and a transformer using the same wherein a coil has a uniform interval and is wound, thus having low leakage inductance, and can be produced without handwork such that a person does not need to peel off the sheath of the wire, and thus is economical and can be mass produced. To this end, an electronic element using a flat coil in a compression type according to an embodiment of the present invention comprises: first and second terminals formed on the first surface of a substrate; an expanding terminal that is electrically connected to the first terminal; an expanding terminal insulating layer covering a part of the expanding terminal; and a first end which is mounted on the first surface of the substrate and is electrically connected to the expanding terminal and a second end ...

Подробнее
25-06-2018 дата публикации

3-INGREDIENT COCRYSTAL

Номер: KR1020180069277A
Принадлежит:

The present invention relates to a manufacturing method for a 3-ingredient cocrystal including kojic acid, tranexamic acid, and nicotinamide. According to the present invention, the manufacturing method for a 3-ingredient cocrystal manufactures a 3-ingredient cocrystal after initially manufacturing a 2-ingredient cocrystal. The 3-ingredient cocrystal shows the most stable solid when a mole fraction of three ingredients in the 3-ingredient cocrystal generated as a result is the tranexamic acid: the nicotinamide: and the kojic acid = 1:1:1 regardless of the mixing ratio of the tranexamic acid, the nicotinamide, and the kojic acid used in the reaction. According to the present invention, the 3-ingredient cocrystal manufactured by the same can be applied in various cosmetic compositions by maintaining physicochemical stability in a case that the 3-ingredient cocrystal manufactured by the same is used in a solid cosmetic composition or a liquid cosmetic composition. COPYRIGHT KIPO 2018 ...

Подробнее